Get started
Author

Laura Salgado‐Boquete

Observed names: L Salgado-Boquete, L. Salgado Boquete, L. Salgado-Boquete, L. Salgado‐Boquete, Laura Salgado, Laura Salgado Boquete, Laura Salgado-Boquete, Salgado Boquete, Laura, Salgado-Boquete, Laura
Observed institutions: Complejo Hospitalario Universitario de Santiago, Corporació Sanitària Parc Taulí, Hospital Universitario de La Princesa, Servicio Gallego de Salud, Complejo Hospitalario de Pontevedra, Universidade de Vigo
ORCID: 0000-0002-0114-5469
Observed ORCID: 0000-0002-0114-5469
OpenAlex ID: A5028722952
Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature
2020 · Deepak M. W. Balak, Sascha Gerdes, et al. · Dermatology and Therapy · 106
PDF
Actualización en hidrosadenitis supurativa en Atención Primaria
2016 · F.J. García-Martínez, J.C. Pascual, et al. · Medicina de Familia SEMERGEN · 80
Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 1. «Conceptos y manejo general de la psoriasis con terapia biológica»
2021 · J.M. Carrascosa, L. Puig, et al. · Actas Dermo-Sifiliográficas · 62
PDF
Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
2020 · Esteban Daudén, Gregorio Carretero, et al. · Journal of the American Academy of Dermatology · 62
A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
2021 · Laura Salgado-Boquete, José Manuel Carrascosa, et al. · Life · 55
Manejo del paciente con hidradenitis supurativa
2016 · A. Martorell, A. Caballero, et al. · Actas Dermo-Sifiliográficas · 46
Intralesional corticosteroid injection for the treatment of hidradenitis suppurativa: a multicenter retrospective clinical study
2019 · Francisco Javier García-Martínez, Eva Vilarrasa Rull, et al. · Journal of Dermatological Treatment · 37
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
2018 · Andrea Montes-Torres, Gloria Aparicio, et al. · Journal of Dermatological Treatment · 35
Actualización práctica de las recomendaciones del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología (GPS) para el tratamiento de la psoriasis con terapia biológica. Parte 2 «Manejo de poblaciones especiales, pacientes con comorbilidad y gestión del riesgo»
2022 · J.M. Carrascosa, L. Puig, et al. · Actas Dermo-Sifiliográficas · 32
PDF
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
2020 · Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, et al. · Journal of the American Academy of Dermatology · 31
El papel del dermatólogo en el diagnóstico precoz de la artritis psoriásica: recomendaciones de un grupo de expertos
2020 · I. Belinchón, L. Salgado-Boquete, et al. · Actas Dermo-Sifiliográficas · 30
PDF
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
2023 · Sonsoles Berenguer‐Ruiz, Mario Aparicio‐Domínguez, et al. · Journal of the European Academy of Dermatology and Venereology · 21
Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain
2021 · Esteban Daudén, Glauber Pacelli Gomes de Lima, et al. · Dermatology and Therapy · 21
PDF
No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients
2023 · Nerea Manzanares, Eva Vilarrasa, et al. · Journal of the European Academy of Dermatology and Venereology · 17
Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
2024 · Esteban Daudén, Elena Escario, et al. · International Journal of Dermatology · 15
PDF
Obesidad: factor de riesgo para psoriasis y COVID-19
2020 · M. Llamas-Velasco, E. Ovejero-Merino, et al. · Actas Dermo-Sifiliográficas · 15
PDF
Teledermatología en edad pediátrica. Observaciones en la práctica clínica diaria
2015 · Ana Batalla, Hae Jin Suh-Oh, et al. · Anales de Pediatría · 15
[Translated article] Practical Update of the Recommendations Published by the Psoriasis Group of the Spanish Academy of Dermatology and Venereology (GPs) on the Treatment of Psoriasis with Biologic Therapy. Part 1. Concepts and General Management of Psoriasis With Biologic Therapy
2022 · J.M. Carrascosa, L. Puig, et al. · Actas Dermo-Sifiliográficas · 14
PDF
Dermatologists’ Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations
2020 · I Belinchón, L Salgado-Boquete, et al. · Actas Dermo-Sifiliográficas · 13
PDF
Adaptación lingüística y cultural al español del cuestionario Psoriatic arthritis UnclutteRed screening Evaluation (PURE-4)
2020 · I. Belinchón, R. Queiro, et al. · Actas Dermo-Sifiliográficas · 13
PDF
Cardiovascular risk factors influence response to biological therapies in psoriasis
2015 · Ana Batalla, Daniel González-Fernández, et al. · Journal of the American Academy of Dermatology · 13
Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting
2022 · Alejandra Reolid, Susana Armesto, et al. · Journal of the American Academy of Dermatology · 12
The effectiveness and safety of ixekizumab in psoriasis patients under clinical practice conditions: A Spanish multicentre retrospective study
2020 · Raquel Rivera, Manuel Velasco, et al. · Dermatologic Therapy · 12
PDF
Epidemiología de la hidradenitis supurativa y de la enfermedad inflamatoria intestinal: ¿son enfermedades que se asocian?
2016 · L. Salgado-Boquete, J. Romaní, et al. · Actas Dermo-Sifiliográficas · 12
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
2023 · Juan José Lluch-Galcerá, Jose Manuel Carrascosa, et al. · British Journal of Dermatology · 11
PDF
Works count: 73
Citation count: 950
H-index: 15
I10-index: 26
Year
Topic
Type